TabletAnti Diabetic

Sitagliptin + Metformin + Pioglitazone

Sitagliptin + Metformin Hydrochloride + Pioglitazone · DPP-4 inhibitor, biguanide and thiazolidinedione combination

TabletAnti Diabetic

Sitagliptin + Metformin + PioglitazoneProspero Healthcare

A tablet combining sitagliptin, metformin and pioglitazone, three antidiabetic agents with complementary actions. It is used in adults with type 2 diabetes mellitus requiring combined therapy for glycaemic control.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sitagliptin + Metformin Hydrochloride + Pioglitazone
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: DPP-4 inhibitor, biguanide and thiazolidinedione combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category